Large-scale testing (Phase 3)Study completedNCT00536393What this trial is testingTreatment of Disseminated High Grade LymphomaWho this might be right forLymphoma French Innovative Leukemia Organisation 100
Large-scale testing (Phase 3)WithdrawnNCT03342300What this trial is testingPegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue SarcomaWho this might be right forProgression-free SurvivalOverall SurvivalToxicity Peking University People's Hospital
Not applicableStudy completedNCT02796365What this trial is testingPrevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via ChemotherapyWho this might be right forDoxorubicin Induced CardiomyopathyBreast CancerGastric Cancer+1 more Henry Ford Health System 29
Early research (Phase 1)Study completedNCT04023110What this trial is testingRisk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or TrastuzumabWho this might be right forCardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more Abramson Cancer Center at Penn Medicine 68
Not applicableStudy completedNCT05731375What this trial is testingMitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE DamageWho this might be right forDoxorubicin Induced CardiomyopathyChemotherapeutic ToxicityAnthracyclines UMC Utrecht 12
Testing effectiveness (Phase 2)Study completedNCT00222105What this trial is testingA Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of LifeWho this might be right forMultiple Myeloma University of Kansas Medical Center 25
Not applicableStudy completedNCT06595758What this trial is testingThis Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCRWho this might be right forBreast Cancer Menoufia University 100
Large-scale testing (Phase 3)Ended earlyNCT00016276What this trial is testingCombination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerWho this might be right forCardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more National Cancer Institute (NCI) 396
Post-approval studies (Phase 4)UnknownNCT05302336What this trial is testingAC vs TC in Patients With HR-positive, HER2-negative Early Breast CancerWho this might be right forBreast CancerChemotherapeutic Toxicity Second Affiliated Hospital, Zhejiang University, School of Medicine 402
Testing effectiveness (Phase 2)Study completedNCT03576521What this trial is testingEvaluation of Ocoxin®-Viusid® in Breast CancerWho this might be right forBreast CancerBreast CarcinomaAdriamycin Toxicity+1 more Catalysis SL 120
Testing effectiveness (Phase 2)UnknownNCT06176339What this trial is testingAssessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"Who this might be right forBreast Cancer Female Mansoura University 70
Testing effectiveness (Phase 2)UnknownNCT01066429What this trial is testingDA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma (DLBCL) Hospital Universitario Principe de Asturias 30
Not applicableStudy completedNCT00875238What this trial is testingSide Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and TrastuzumabWho this might be right forBreast CancerCardiac ToxicityCardiovascular Complications Vanderbilt University 133
Not applicableUnknownNCT04654195What this trial is testingStudy of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer PatientWho this might be right forBreast Cancer Patients Damanhour University 100
Early research (Phase 1)Study completedNCT00005830What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more Gynecologic Oncology Group 31
Not applicableUnknownNCT05733026What this trial is testingEffect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer PatientsWho this might be right forBreast Cancer Ain Shams University 200
Testing effectiveness (Phase 2)Study completedNCT00436566What this trial is testingDoxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryWho this might be right forBreast CancerCardiac Toxicity Mayo Clinic 122
Not applicableStudy completedNCT03908528What this trial is testingAlpha-Lipoic Acid in Breast Cancer PatientsWho this might be right forBreast CancerChemotherapeutic Toxicity Damanhour University 64
Early research (Phase 1)Ended earlyNCT03646188What this trial is testingDose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)Who this might be right forBasal Cell Carcinoma SkinJect, Inc. 13
Not applicableStudy completedNCT03027063What this trial is testingImpact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.Who this might be right forBreast Cancer FemaleAdriamycin Toxicity Johns Hopkins University 21